Regency Capital Management’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Regency Capital Management’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-18,000	Closed	-$647K	–	42
2022 Q4	$647K	Sell	18,000 -10	-0.1%	-$250	0.74%	25
2022 Q3	$271K	Sell	18,010 -40	-0.2%	-$649	0.33%	35
2022 Q2	$242K	Buy	+18,050	New	+$286K	0.26%	35

Regency Capital Management's IMGO Position: Q1 2023 in Review

Regency Capital Management sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 18,000 shares — an estimated $647K sold.

Regency Capital Management first reported a position in IMGO in Q2 2022 and held it in 3 quarters. The position peaked at $647K in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

Regency Capital Management reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
Regency Capital Management sold 18,000 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $647K.
Regency Capital Management first reported a position in Imago BioSciences, Inc. Common stock in Q2 2022 and held it in 3 quarters.
Regency Capital Management's Imago BioSciences, Inc. Common stock position peaked at $647K in Q4 2022.
0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Regency Capital Management's 13F filing for Q1 2023, filed 8 May 2023.